报价延迟最少15分钟:2026/03/30 06:57 EDT
盘前时段
|
||||
|
-- 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.32
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.74/0.48
|
|
企业价值
144.50M
|
| 资产负债 |
|
每股账面净值
-1.91
|
| 现金流量 |
|
现金流量率
0.71
|
| 损益表 |
|
收益
192.22M
|
|
每股收益
5.88
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries. |
